Background -Fascicular ventricular tachycardia (FVT) is a common form of sustained
Since the first description of fascicular ventricular tachycardia (FVT) involving the left posterior fascicle (LPF) in 3 patients by Zipes et al in 1979, our understanding of this common form of idiopathic left ventricular tachycardia has expanded particularly over the last 2 decades. 1 Through detailed electrophysiological studies, FVT has been determined to be re-entrant in mechanism, can be responsive to verapamil, involves various branches of Purkinje network emanating from left fascicles with differential conduction properties participating in the tachycardia and can be successfully treated by localized ablation in the left ventricular septum. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] Based on reports of small single-center cohorts undergoing ablation, acute success rates are generally high although limited data exist about electrophysiological findings and clinical outcomes in the few patients that do develop arrhythmia recurrence. More recently, case reports have described FVT patients re-presenting years after ablation with different variants of FVT. 15, 16 This study aimed to prospectively investigate long term clinical outcomes of a large cohort of patients undergoing catheter ablation of FVT in a regional referral center in China, analyze mechanisms of arrhythmia recurrence and identify electrophysiological or clinical predictors for FVT recurrence.
Methods

Population
The study was approved by an institutional ethics committee and that all subjects gave informed were recorded at baseline and at the end of the procedure. Particular attention was paid to the development of fascicular block after ablation. Specifically, LPF block was defined as frontal axis between 90° to 180º, rS pattern in leads I and aVL, qR pattern in leads III and aVF and QRS duration of less than 120ms as per the most recent international guidelines. 17 In patients without spontaneous VT, programmed stimulation was performed from the RV apex, RV outflow tract and right atrium at drive trains of two different cycle lengths (500 or 400 ms, and 330 ms), with up to three extra stimuli, with and without the use of isoproterenol axis betwe we ween 90°0°0 to 18 8 80º 0º 0 , , rS p p pat at atte t t rn in leads I I I an an nd d d aV aV a L, ,R R R pa p p ttern in in in leads I I III I and n n aVF and QRS du du dura ra rati ti t on on on o o of f le le ess ss ss t t tha ha han n n 12 12 120m 0m 0ms s s as as as p p per er er t t the he e m m mos os ost t t re re rece ce cent nt nt in inte te tern rn rnat at atio io ona na nal l gu gu guid id del el elin in ines es es. . . 17 17 7 entrainment. the LV geometry ( Figure 1 ). During cases where only conventional mapping was performed, sites with the earliest pre-systolic Purkinje potential during VT was identified ( Figure 2 ).
Activation Mapping
Whenever possible, entrainment was performed to confirm participation of the targeted site in VT. If VT was not inducible, catheter ablation was not performed.
Radiofrequency Ablation
Temperature-controlled radiofrequency energy was delivered at the site with the earliest pre-systolic Purkinje potential during VT. The power output was titrated to as high as 35W to achieve a target temperature of 40 to 60 C for up to 120 seconds. The ablation procedure was considered successful if FVT terminated during ablation and/or any VT was not inducible 30 minutes after ablation despite repeat programmed stimulation and isoproterenol infusion.
Follow-Up
After the procedure, continuous ECG monitoring was performed for 24 hours. All anti-arrhythmic agents were not restarted in the absence of post-operative arrhythmia recurrence.
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Ra Ra Radi di diof of ofre re requ qu quen en enc c cy y y Ab Ab Abla la lati ti tion on on All patients were reviewed in clinic monthly after the procedure for the first three months, and then followed up every 6 months. A 12-lead ECG and 24-hour Holter monitoring were performed at every clinic visit. Arrhythmia recurrence was defined as symptomatic recurrence with ECG documentation of recurrent VT on either the 12-lead ECG and/or Holter monitoring.
Statistical Analysis
Continuous variables and categorical variables were described by means ± standard deviation and percentages, respectively. An independent samples t-test and paired samples t test were performed for comparisons of the corresponding parameters and paired data. Chi-square test was used for comparison of categorical data. To determine the association between procedural parameters and VT recurrence, univariable and multivariable Cox proportional regression analyses were performed and results were expressed as hazard ratios (HRs) with 95% confidence intervals (CIs). P-value of less than 0.05 was considered as statistically significant.
Results
Patient Characteristics
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Predictors of ILVT Recurrence
Multivariable analysis was performed to identify risk factors for LPFVT recurrence after an acutely successful ablation procedure (Table 3) . Only faster VT cycle lengths predicted LPFVT recurrence. (VT cycle length in patients with and without LPFVT recurrence, 307.7 ± 49.6 ms vs.
361.7 ± 62.7, P = 0.03). Development of LPF block did not protect against LPFVT recurrence.
Discussion
Major Findings
Our strategy of targeting the most premature pre-systolic Purkinje potential with limited ablation during ongoing FVT is associated with high acute procedural success (100%) although approximately 20% of patients subsequently developed arrhythmia recurrence. Two-thirds of FVT recurrence was caused by the re-appearance of same FVT that was treated during the index ablation whereas the rest was caused by new-onset upper septal VT. Shorter tachycardia cycle length was the sole predictor of LPFVT recurrence. The development of new LPF block was associated with more basal ablations and did not protect against LPFVT recurrence.
Identifying Targets for FVT Ablation
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latter representing the lower turnaround of the LPFVT circuit. 8, 10 The advantages of targeting the earliest PP include their more apical locations, reducing the risk of atrioventricular nodal or bundle branch injury and need for fewer radiofrequency energy applications. 18 Furthermore, diastolic (P1) potentials may not be recorded in all patients. 8 Although different smaller series have selected varying ablation targets namely P1, earliest PP or even the exit site (site with earliest ventricular activation), acute success rates are consistently high, suggesting that the reentrant FVT can be interrupted at multiple points alongst the re-entrant circuit. 8, 9, 11, 18 Consistent with these prior reports, our pre-defined strategy of targeting the earliest PP during LAFVT or LPFVT was acutely successful in all patients.
Electrophysiological Endpoints of FVT Ablation
Locating the optimal site for ablation becomes more difficult when FVT is difficult to induce or is non-sustained. Numerous ablation strategies performed during sinus rhythm to overcome this hurdle have been reported. Purkinje potentials visible after the QRS complex, which may be characteristic of delayed retrograde activation of abnormal Purkinje fibers that act as the anterograde limb of LPFVT, have been targeted during sinus rhythm. Whilst these potentials seem unique to FVT patients compared to a small group of control patients without FVT, such electrograms are recordable over a sizeable area of the septum and can be detected remotely in the left anterior fascicle Purkinje network in patients presenting with LPFVT. 4, 10 Thus, undertaking such a strategy would result in a substantial septal area being ablated with the risk of injury to the conducting system. A more anatomically guided approach of placing 7 to 15 ablation lesions in a linear pattern, perpendicular to the long axis of the ventricle approximately midway from the base to the apex in the region of the mid to mid-inferior septum, guided by the presence of Purkinje potentials and pace mapping was reported to be effective in 6 patients with
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hu hu urd d dle l have be been n n r r repo or rte e ed. P P Pur ur urki k nje e po po p t t ten n ntia als ls visi i ibl l le af af afte te ter t t the e e QR R RS S S com mp mple l x x x, w w which h h ma ma may be characteri ri rist s s ic of f f de d d laye ye yed d d retrog og ogra ra rade activatio on n n of of f ab ab abno n n rmal al al Purkinj j je e e fi f bers th h hat a a a act c c as the an an ante te tero ro rogr gr grad ad ade e e li limb mb b o o of f f LP LP LPFV FV FVT, T, T, ha ha ave ve ve b b bee ee een n n t t tar ar arge ge gete te ted d d du du duri ring ng ng s s sin inus us us r r rhy hy hyth th thm m m. . . Wh Wh Whil ilst st st t t the he ese se se p p pot ot oten en enti ti tial al a s s s non-sustained LPFVT. 6 Consistent with our results that the successful ablation site is located on average 69% of the septal course extending from the bundle of His to the end of the left fascicle, it is highly plausible that such lesion sets could transect the lower turnaround of the LPFVT circuit, preventing arrhythmia recurrence. Finally, a few groups have suggested creation of partial or complete LPF block as a reproducible, easily demonstrable electrophysiological endpoint for LPFVT ablation. 7, 14, 19 In our study, the development of complete LPF block was associated with more basally located ablations. Furthermore, the formation of LPF block did not reduce the risk of LPFVT recurrence. These findings, in conjunction with other observations that selective capture of the LPF during LPFVT did not affect tachycardia cycle length; LPFVT can still develop in patients with pre-existing LPF block and the vast majority of patients remained arrhythmia-free after LPFVT ablation without developing new onset LPF block; would suggest that the LPF does not participate in LPFVT circuit. 5, 13, 20 Hence rightward shift in the ECG axis is most likely due to inadvertent collateral damage to the LPF, particularly when ablation is delivered more basally. Therefore, our results would imply that creation of LPF block is unlikely to be an effective electrophysiological endpoint for FVT ablation, although this hypothesis was not tested directly in the experimental design. It is also noteworthy that 5 out of 6 patients who developed arrhythmia recurrence with upper septal VT developed LPF block after their first index. It is speculative but plausible that the inadvertent creation of sites of slow conduction within the Purkinje network could be pro-arrhythmic, promoting re-entry alongst different septal circuits.
Predictors of FVT Recurrence
In an earlier study of 79 patients whom underwent ablation of idiopathic VT which included 40
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In our study with a larger sample size, only faster tachycardia cycle length but not prematurity of the local PP potential, predicted FVT recurrence. More rapid ventricular contractions may lead to reduced catheter stability and tissue contact, impairing ablation lesion size and quality.
Subsequent recovery of conduction between the anterograde and retrograde limbs of the LPFVT circuit allowed for VT recurrence. Hence during the repeat procedure, the successful ablation site was once again mapped to a similar location and additional ablation rendered once again FVT non-inducible.
Potential for Multi-fascicular VT
Upper septal VT is the most uncommon variant of fascicular VT, characterized by a tachycardia circuit that utilizes parts of the LPF as the anterograde limb (with simultaneous bystander activation of the right bundle and left anterior fascicle to produce a narrow QRS) and septal
Purkinje fiber or auxiliary fascicle as the retrograde limb. 15, 16 Such VT has also been described as fast-slow fascicular VT whereby the slower conducting septal fascicle serves as the retrograde limb as opposed to the fast-slow fascicular VT seen in LAFVT and LPFVT whereby anterograde limb is the slower conducting abnormal Purkinje fibre. 21 It has been reported by Nishiuchi et al. recently that upper septal VT was responsible for arrhythmia recurrence in a patient who had previously undergone successful ablation of LPFVT, similar to 6 patients in our cohort. 15 However, upper septal VT can also present as the de novo arrhythmia. 16 Unlike LPFVT, it is important to target the earliest diastolic potential originating from the septal fascicle which marks 
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mapping of upper septal VT (Panel D), the earliest DP is targeted (white arrow). Th Th The e e lo lo loca ca cal l l ac cti ti tiva va vati ti tion a a at t t e e each ch ch s site was measured by annotating g g th h he local His / Pu Pu P rkin n nje je je potential, rather than h h he ve v ntricular el l lec c ctrog g gr ra ram. 
